Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine

Internal Medicine
Takanori IchikawaYoshiki Sekijima

Abstract

Adult-onset Still's disease (AOSD) sometimes demonstrates hematologic disorder, whereas acquired amegakaryocytic thrombocytopenia (AAT) involvement is extremely rare. We herein report a 67-year-old woman with relapse of AOSD who concomitantly developed AAT. Thrombocytopenia along with high disease activity of AOSD was resistant to high-dose prednisolone, even in combination with methotrexate and tacrolimus. However, alternative treatment with cyclosporine after administering tocilizumab resulted in the improvement of thrombocytopenia, ultimately demonstrating that combination therapy based on suppressing the intractable disease activity of AOSD and subsequently adding a reliable immunosuppressant was required to achieve remission.

References

Feb 1, 1981·Annals of Internal Medicine·D B StollS Murphy
Mar 29, 2002·The New England Journal of Medicine·Douglas B Cines, Victor S Blanchette
Nov 9, 2005·European Journal of Internal Medicine·Antonio G Tristano
Jan 25, 2006·American Journal of Hematology·Neeraj AgarwalGeorge M Rodgers
Apr 18, 2007·Modern Rheumatology·Kosaku MurakamiTsuneyo Mimori
Jun 14, 2008·Alimentary Pharmacology & Therapeutics·S YamamotoT Chiba
Jan 18, 2014·Clinical Rheumatology·Petros EfthimiouBella Mehta
Mar 25, 2014·Autoimmunity Reviews·Mathieu Gerfaud-ValentinPascal Sève
Nov 11, 2014·Modern Rheumatology·Yu Funakubo AsanumaTakayuki Sumida
Apr 22, 2015·Nature Immunology·Christopher A Hunter, Simon A Jones
Jul 28, 2016·International Journal of Rheumatic Diseases·Ken-Ichi UenoShu-Ichi Ikeda

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.